- Home
- BVS vs BOE Comparison
BVS vs BOE Comparison
Compare BVS & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVS
- BOE
- Stock Information
- Founded
- BVS 2011
- BOE 2005
- Country
- BVS United States
- BOE United States
- Employees
- BVS N/A
- BOE N/A
- Industry
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BOE Trusts Except Educational Religious and Charitable
- Sector
- BVS Health Care
- BOE Finance
- Exchange
- BVS Nasdaq
- BOE Nasdaq
- Market Cap
- BVS 656.9M
- BOE 634.0M
- IPO Year
- BVS 2021
- BOE N/A
- Fundamental
- Price
- BVS $7.82
- BOE $10.19
- Analyst Decision
- BVS Strong Buy
- BOE
- Analyst Count
- BVS 4
- BOE 0
- Target Price
- BVS $15.00
- BOE N/A
- AVG Volume (30 Days)
- BVS 339.2K
- BOE 166.1K
- Earning Date
- BVS 05-06-2025
- BOE 01-01-0001
- Dividend Yield
- BVS N/A
- BOE 7.30%
- EPS Growth
- BVS N/A
- BOE N/A
- EPS
- BVS N/A
- BOE N/A
- Revenue
- BVS $573,280,000.00
- BOE N/A
- Revenue This Year
- BVS N/A
- BOE N/A
- Revenue Next Year
- BVS $6.09
- BOE N/A
- P/E Ratio
- BVS N/A
- BOE N/A
- Revenue Growth
- BVS 11.89
- BOE N/A
- 52 Week Low
- BVS $3.90
- BOE $8.80
- 52 Week High
- BVS $14.38
- BOE $10.48
- Technical
- Relative Strength Index (RSI)
- BVS 37.22
- BOE 39.87
- Support Level
- BVS $7.56
- BOE $10.16
- Resistance Level
- BVS $8.66
- BOE $10.61
- Average True Range (ATR)
- BVS 0.61
- BOE 0.31
- MACD
- BVS -0.05
- BOE 0.00
- Stochastic Oscillator
- BVS 28.40
- BOE 59.54
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.